News
SMB News

SMB News

  • Galen Gorence to receive President’s Employee Excellence Award

    Galen, the animal care facility manager for SMB, is not only in charge of the day-to-day operations of the animal facilities but he also provides instruction to his staff about animal husbandry, oversight of equipment maintenance and advice to faculty on breeding habits and other factors that potentially could affect research data. Gorence has displayed outstanding ability and worked extra hours to accommodate a construction project that required moving animals and equipment and decontaminating facilities. He is applauded for his anticipation of problems and solutions in a way that causes minimal disruption to research.  He will be honored at the Celebrating Excellence Recognition Banquet on March 28, as part of the Washington State University  annual Showcase celebration.
  • Provost and VP of Research Invest in the Laboratory for Biotechnology and Bioanalysis

    Interim Provost Bernardo and Interim VP for Research Magnuson have provided substantial funds to support service agreements for several highly used instrument in the Laboratory for Biotechnology and Bioanalysis, Dr. Griswold, Director of the Laboratory, announced today. These monies affirm the commitment of the institution to the Laboratory which is used by numerous research labs on the WSU campus. Dr. Jones, Director of SMB, thanks Dr. Griswold and the staff of the Laboratory for their exemplary service and efforts on behalf of the user base of this important and outstanding core.  


  • Subra Muralidharan awarded Nanomedicine Nature of Homeopathic Medicines for Cancer: Developmental Project

    Nanomedicine Nature of Homeopathic Medicines for Cancer: Developmental ProjectLotte and John Hecht Memorial Foundation - Jan 2014 - Jan 2016
    The Foundation supports research in complimentary and alternative medicine (CAM).  Prevailing hypothesis of the efficacy of homeopathic remedies is that the way they are prepared results in nanoparticles with the drug molecules embedded in them.  This facilitates ready cell transport and targeted delivery of drugs to diseased cells.  The focus of my project will be to embed specific homeopthic drugs that have shown efficacy for glioblastoma in nanoparticles of slilca and calcium phosphate in a controlled manner and and study their interaction with glioma cells.  The goal is to understand the nanomedicine-cell interaction at the molecular level and propose possible mechanism of the action of these drugs.  The initial focus will be on mitochondrial DNAs that upregulate metabolic pathways considered to be key in glioma cell proliferation.


  • Raymond Reeves to present the Distinguished Faculty Address

    Dr. Reeves will present the distinguished faculty address as part of the 2014 Showcase celebration of Washington State University research, scholarship and creative work.  The address will be at 3:30 p.m. Thursday, March 27, in the science forum on the third floor of the Veterinary and Biomedical Research Building.
    This annual award from Washington State University recognizes a faculty member whose achievements in research, scholarship and teaching place him or her in the front ranks of his or her discipline. Reeves is one of the most highly cited scientists at WSU and in 2010 was elected a Fellow of the American Association for the Advancement of Science for contributions to the field of chromatin research, particularly for studies elucidating the structure and function of the HMGA family of non-histone architectural proteins.  http://news.wsu.edu/2014/02/04/reeves-will-present-distinguished-faculty-address/


  • Congratulations to Our Newest PhD and MSc Graduates!

    The following thesis and dissertation students graduated with the December 2013 class:

    Kris Christensen successfully completed the requirements for the degree Doctor of Philosophy in Genetics and Cell Biology. The title of his defense was:  Antipredator Behavior in Rainbow Trout Clonal Lines Derived from Wild and Hatchery Populations 

    Derrick Samuelson successfully completed the requirements for the degree Doctor of Philosophy in Molecular Biosciences. The title of his defense was:  The Identification and Characterization of a Campylobacter jejuni Virulence Protein 

    Katie Clayton successfully completed the requirements for the degree Master of Science in Molecular Biosciences. The title of her seminar was:  Effects of a Broad-Spectrum Antibiotic on the Bacterial Microbiome of the Rocky Mountain Wood tick, Dermacentor andersoni


  • Dr. John Alderete’s Research on Sexually Transmitted Diseases and Infections (STIs) Recognized

    Congratulations to Dr. Alderete who earlier this year was invited by the World Health Organization (WHO) as a technical consultant on its “Global Action Plan and Road Map for STI Vaccine Development” panel held in Geneva Switzerland in April.  More recently Dr. Alderete was invited by the President of the National Academy of Science of Spain to give a Plenary Talk on his research to the Royal Academy of Veterinary Sciences (Real Academia de Ciencias Veterinarias) in Madrid in June.  In September he also presented the invited Keynote Address at the “2013 Michigan Regional AGEP (Alliance for Graduate Education and the Professoriate) fall conference to graduate students, postdoctoral fellows, and faculty at Michigan State University in East Lansing.
  • Dr. Hunt part of WSU Common Reading Lecture Series

    Professor Patricia Hunt talks to students about how ‘One Mistake Changed Her Career” as part of the WSU Common Reading Lecture Series.  For more details go to: Daily Evergreen
  • Dr. Hunzicker-Dunn invited to speak at three Named Lectures this Fall

    Congratulations to Professor Mary Hunzicker-Dunn who has been invited to present three Named Lectures this Fall: 1.) MIP Retreat Keynote and Distinguished Alumni Lecture at the University of Illinois, Champaign/Urbana, on Sept 27.  2.) The Anita Payne Lectureship, Oct 4.  3.) 10th Annual Gilbert S Greenwald Plenary Lecture, Oct 18.


  • Position Opening for Assistant/Associate/Full Professor in SMB

    The School of Molecular Biosciences in the College of Veterinary Medicine at Washington  State  University  in  Pullman, WA  and  its  new  Director  Dr.  Jonathan Jones, seek to hire outstanding individuals for tenure-track positions at the rank of Assistant, Associate, or Full Professor (http://www.smb.wsu.edu/). Successful candidates will have the opportunity of establish their research programs in a state-of-the-art   building specifically   designed   and   equipped   for biological research. The research interests of applicants should complement the existing focus areas of the School.  These include reproductive   biology, signal transduction in model organisms, cell adhesion/cytoskeleton and live cell imaging, DNA repair and chromosome biology, microbial genetics and infectious disease.

    For more information:  www.wsujobs.com/applicants/Central?quickFind=58824

  • Margaret Black's research developed the thermostabilized suicide enzyme currently being used in clinical trials for brain tumors

    New advances in the treatment of brain cancers such as glioblastomas are being investigated in clinical trials using Toca 511, a novel suicide gene therapy.  Toca 511 is a replicative virus that produces a suicide enzyme (yeast cytosine deaminase) able to convert 5-fluorocytosine, an anti-fungal agent to a potent anti-cancer drug.  This therapy is an advancement to traditional chemotherapy in which all cells in the patient are exposed to drug.  Suicide gene therapy restricts the production of the chemotherapeutic drug at the tumor site, thus limiting exposure to the drug.  Work by Dr. Margaret Black, Professor in WSU's School of Molecular Biosciences, and collaborators at the Fred Hutchinson Cancer Research Center and the University of Washington led to the development of the thermostabilized suicide enzyme used in the clinical studies described in this video.  Computational design, biochemical characterization, as well as in vitro and in vivo studies performed by Black and collaborators provided basic research used in this investigational new clinical therapy.  Video